Skip to main content
OpenTrials

Clinical trial condition

Peripheral Vascular Diseases

Explore clinical trials studying Peripheral Vascular Diseases. Study availability and eligibility vary by location and protocol.

304 public trials 29 recruiting studies
Refine in advanced search Browse all conditions

Peripheral Vascular Diseases trial results

Completed

Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mortality

NCT02668250

Conditions
Alcohol-Related Disorders, Alcoholism, Arrhythmias, Cardiac, +42 more
Locations
  • CHU Amiens - Picardie Amiens, France
  • CHU CAEN Caen, France
  • Chu Clermont-Ferrand Clermont-Ferrand, France
  • Médipôle Lyon - Villeurbanne Décines-Charpieu, France
View all 29 locations
View Trial Details
Completed

The DESappear Study: Drug Eluting Scaffold

NCT02869087

Conditions
Cardiovascular Diseases, Peripheral Vascular Disease, Peripheral Vascular Diseases, +1 more
Locations
  • LKH University Hospital Graz Graz, Styria, Austria
  • Hanusch Hospital Vienna, Austria
  • AZ Sint Blasius, Dendermonde Dendermonde, Brussels Capital, Belgium
  • Heilig Hart Hospital Tienen, Belgium
View Trial Details
Completed

An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI)

NCT01483898

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +11 more
Locations
  • Cardiology PC Birmingham, Alabama, United States
  • Cardio-Thoracic Surgeons, P.C. Birmingham, Alabama, United States
  • University Of Alabama At Birmingham Birmingham, Alabama, United States
  • Arizona Heart Institute Phoenix, Arizona, United States
View all 86 locations
View Trial Details
Completed

Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets

NCT00442325

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Brain Diseases, +23 more
Locations
  • Pfizer Investigational Site Ioannina, Greece
  • Pfizer Investigational Site Kallithea, Athens, Greece
  • Pfizer Investigational Site Pireaus, Greece
  • Pfizer Investigational Site Thessaloniki, Greece
View all 32 locations
View Trial Details
Completed

Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)

NCT00442845

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Brain Diseases, +23 more
Locations
  • Pfizer Investigational Site Mississauga, Ontario, Cameroon
  • Pfizer Investigational Site Calgary, Alberta, Canada
  • Pfizer Investigational Site Edmonton, Alberta, Canada
  • Pfizer Investigational Site Medicine Hat, Alberta, Canada
View all 121 locations
View Trial Details

Related conditions